fall
light
influenza
pandem
children
hospit
michigan
chm
institut
polici
requir
combin
contact
gown
glove
droplet
mask
isol
precaut
inpati
uri
symptom
determin
appropri
isol
precaut
hospit
pediatr
patient
potenti
respiratori
coinfect
import
intervent
prevent
health
careassoci
infect
hai
cohort
patient
clinic
bronchiol
symptom
also
recommend
center
without
privat
patient
room
admiss
howev
clinic
bronchiol
may
caus
etiolog
agent
use
rapid
respiratori
test
platform
give
clinician
inform
may
allow
focus
isol
cohort
patient
real
time
studi
hypothesi
use
combin
isol
precaut
continu
even
pandem
pediatr
patient
uri
symptom
base
detect
pathogen
coinfect
use
small
volum
polymeras
chain
reaction
svpcr
array
respiratori
panel
rp
requir
droplet
contact
isol
precaut
svpcr
array
rp
first
us
food
drug
administr
fda
approv
molecular
method
capabl
detect
viral
bacteri
respiratori
pathogen
compar
molecular
test
method
detroit
medic
center
us
site
involv
clinic
evalu
filmarray
respiratori
panel
biofir
diagnost
inc
previous
idaho
technolog
inc
salt
lake
citi
ut
januari
april
septemb
decemb
sampl
collect
mayaugust
pediatr
patient
age
year
present
emerg
depart
ed
chm
tertiari
pediatr
medic
center
detroit
michigan
offer
particip
studi
treat
clinician
order
test
viral
respiratori
pathogen
admit
patient
specimen
collect
hospit
protocol
requir
studi
patient
one
follow
sign
symptom
suggest
respiratori
infect
fever
cough
sore
throat
runni
nose
pain
pressur
ear
sinu
pressur
andor
sneez
studi
coordin
confirm
treat
clinician
patient
exhibit
record
sign
symptom
patient
enrol
studi
studi
approv
wayn
state
univers
human
investig
committe
laboratori
offer
rapid
antigen
test
rat
base
later
flow
immunochromatograph
method
respiratori
virus
binaxnow
rsv
binax
scarborough
quickvu
influenza
b
quidel
san
diego
ca
perform
accord
manufactur
instruct
respiratori
viru
cultur
patient
specimen
inocul
monolay
cell
cultur
tube
rhesu
monkey
kidney
human
fetal
lung
fibroblast
cell
line
binax
scarborough
except
tube
incub
c
observ
daili
develop
cytopath
effect
cpe
cpe
develop
depend
appear
cell
react
appropri
fluoresc
antibodi
influenza
influenza
b
parainfluenza
virus
adenoviru
respiratori
syncyti
viru
rsv
ultra
respiratori
screen
identif
kit
diagnost
hybrid
c
tube
respiratori
cultur
older
day
show
cpe
test
hemadsorpt
use
guinea
pig
red
blood
cell
virom
minnetonka
mn
hemadsorb
virus
includ
influenza
b
parainfluenza
virus
hemadsorptionposit
cultur
test
fluoresc
antibodi
describ
potenti
shorten
time
diagnosi
remain
cell
cultur
incub
c
cpe
characterist
rhinoviru
seen
cultur
sign
presumpt
rhinoviru
techniqu
detect
coronaviru
human
metapneumoviru
hmpv
human
bocaviru
hbcv
viral
cultur
monitor
day
cpe
report
neg
filmarray
respiratori
panel
assay
biofir
diagnost
inc
svpcr
assay
design
detect
respiratori
pathogen
simultan
nasopharyng
np
swab
freezedri
reagent
nucleic
acid
purif
revers
transcript
nest
multiplex
pcr
highresolut
melt
analysi
contain
within
proprietari
reagent
pouch
inocul
patient
respiratori
specimen
filmarray
respiratori
panel
test
identifi
common
emerg
bacteri
viral
respiratori
pathogen
adenoviru
hbcv
bordetella
pertussi
chlamydophila
pneumonia
coronavirus
hmpv
rhinoviru
enteroviru
influenza
virus
influenza
b
mycoplasma
pneumonia
parainfluenza
virus
rsv
may
fda
clearanc
obtain
hbcv
filmarray
respiratori
panel
test
result
compar
rat
viral
cultur
result
part
clinic
evalu
system
result
analyz
local
coinfect
trend
per
studi
protocol
result
filmarray
respiratori
panel
test
share
treat
clinician
suggest
isol
precaut
recommend
specif
respiratori
pathogen
base
method
transmiss
prevent
hai
respiratori
isol
precaut
recommend
influenza
virus
b
pertussi
pneumonia
contact
isol
precaut
recommend
rsv
hmpv
hbcv
parainfluenza
virus
standard
precaut
recommend
coronavirus
c
pneumonia
dual
contact
respiratori
isol
precaut
recommend
adenoviru
statist
analysi
pearson
c
test
use
compar
agebas
differ
detect
rsv
hmpv
fisher
exact
test
use
compar
agebas
differ
pathogen
detect
compar
none
detect
singl
multipl
detect
pathogen
five
hundr
three
np
swab
obtain
pediatr
patient
offer
particip
studi
physician
order
test
respiratori
pathogen
patient
parentguardian
offer
particip
studi
refus
consent
enrol
valid
svpcr
array
rp
result
sampl
pass
intern
qualiti
control
within
assay
male
femal
age
rang
week
year
mean
ae
year
median
year
patient
age
month
younger
children
age
month
older
patient
age
design
chosen
infant
young
children
contain
secret
requir
close
physic
contact
patient
care
may
lead
increas
risk
transmiss
pathogen
commonli
report
symptom
runni
nose
cough
fever
median
number
report
symptom
rang
symptom
standard
techniqu
util
rat
rsv
influenza
ab
viral
cultur
yield
posit
result
least
pathogen
sampl
rat
posit
rsv
influenza
sampl
viral
cultur
posit
sampl
rsv
adenoviru
enteroviru
parainfluenza
parainfluenza
influenza
influenza
b
rsv
detect
rat
alon
time
cultur
alon
time
rat
cultur
time
influenza
detect
time
cultur
alon
time
rat
cultur
sampl
test
posit
standard
techniqu
gave
neg
svpcr
array
rp
result
includ
viral
cultur
posit
adenovirus
enteroviru
influenza
viru
last
confirm
posit
influenza
rat
one
addit
sampl
posit
rsv
rat
neg
viral
cultur
svpcr
array
rp
one
patient
posit
rat
rsv
discord
viral
cultur
grew
adenoviru
patient
svpcr
array
rp
identifi
rsv
well
adenoviru
sampl
test
svpcr
array
rp
higher
standard
techniqu
posit
total
pathogen
tabl
includ
specimen
younger
children
older
patient
differ
signific
p
exclud
coronavirus
hmpv
hbcv
routin
virolog
diagnost
assay
detect
svpcr
array
rp
detect
virus
higher
standard
techniqu
least
pathogen
detect
standard
techniqu
correl
least
pathogen
detect
svpcr
array
rp
result
except
case
note
bacteri
infect
detect
b
pertussi
pneumonia
pathogen
frequent
identifi
svpcr
array
rp
rsv
hmpv
rsv
detect
significantli
higher
younger
children
compar
older
patient
p
frequenc
pathogen
commonli
detect
svpcr
array
rp
test
studi
month
shown
figur
fever
qualifi
sign
symptom
singl
inclus
criterion
enrol
particip
viral
respiratori
test
order
treat
clinician
nine
posit
svpcr
array
rp
result
posit
result
includ
rsv
parainfluenza
one
particip
coinfect
parainfluenza
pathogen
identifi
svpcr
array
rp
specimen
total
test
posit
test
posit
fig
multipl
pathogen
detect
younger
children
total
posit
svpcr
array
rp
older
patient
total
posit
svpcr
array
rp
test
age
differ
number
coinfect
signific
p
coinfect
would
requir
combin
contact
droplet
isol
precaut
gown
glove
mask
base
pathogen
combin
identifi
combin
precaut
also
recommend
adenoviru
detect
singli
infect
patient
therefor
least
pathogen
identifi
month
pathogen
test
number
small
z
rsv
detect
differ
significantli
children
age
month
combin
compar
month
p
valu
x
coronaviru
valu
combin
total
within
age
categori
includ
test
would
requir
combin
isol
precaut
fig
estim
theoret
number
children
may
assign
wrong
level
isol
precaut
rat
svpcr
array
rp
assay
result
avail
time
impact
isol
precaut
determin
cultur
significantli
slower
thu
rat
svpcr
array
rp
result
use
calcul
rat
posit
compar
least
pathogen
identifi
svpcr
array
rp
differ
assay
standard
test
rat
could
wrongli
assign
isol
precaut
either
precaut
fals
neg
rat
singl
precaut
dual
precaut
coinfect
base
increas
yield
svpcr
array
rp
posit
test
result
total
particip
co
evalu
svpcr
array
rp
tertiari
care
children
hospit
particip
enrol
tradit
month
respiratori
pathogen
infect
children
svpcr
array
rp
assay
rapid
take
minut
handson
timesampl
requir
special
molecular
train
oper
svpcr
array
rp
detect
least
pathogen
np
sampl
wherea
standard
rat
viru
cultur
techniqu
detect
total
svpcr
array
rpdetect
pathogen
rate
middl
rang
studi
use
molecular
method
respiratori
pathogen
detect
report
posit
rate
rang
base
svpcr
array
rp
result
signific
differ
number
children
month
younger
detect
pathogen
compar
age
month
greater
differ
may
relat
develop
immun
system
younger
age
group
lack
previou
viru
exposur
earli
life
possibl
colon
month
older
present
uri
symptom
may
variou
nonsvpcr
array
rp
test
pathogen
caus
symptom
fdaclear
svpcr
array
rp
assay
packag
insert
report
sensit
specif
base
pediatr
adult
data
children
year
obtain
prospect
clinic
evalu
svpcr
array
rp
assay
exclud
bocaviru
patient
popul
coinfect
pathogen
includ
bacteria
includ
svpcr
array
rp
note
svpcr
array
rpposit
specimen
detect
pathogen
investig
also
report
mix
viral
infect
coinfect
children
one
studi
finland
util
pcr
diagnost
assay
includ
serolog
note
mix
viral
infect
sampl
studi
respiratori
rhinovirus
enterovirus
among
commonli
identifi
virus
mix
infect
studi
franc
found
pcrposit
nasal
aspir
sampl
contain
least
virus
addit
german
group
report
pediatr
patient
acut
respiratori
tract
infect
posit
test
result
viru
two
molecular
studi
seattl
wa
detect
viral
coinfect
patient
least
identifi
viral
pathogen
pediatr
patient
symptom
bronchiol
neither
report
suggest
test
identifi
respiratori
picornavirus
perform
howev
multicent
studi
mansbach
et
al
report
infant
children
year
age
bronchiol
multipl
pathogen
detect
includ
rhinoviru
identif
viral
coinfect
associ
differ
clinic
outcom
exampl
aramburo
et
al
use
realtim
pcr
detect
respiratori
virus
critic
ill
children
respiratori
tract
diseas
report
children
sampl
viral
pathogen
patient
viral
coinfect
patient
viral
coinfect
higher
mortal
rate
although
statist
signific
anoth
studi
patient
hematolog
disord
signific
differ
note
present
outcom
episod
febril
neutropenia
caus
bacteri
infect
caus
mix
viral
bacteri
infect
combin
pathogen
especi
coinfect
rsv
associ
longer
length
stay
treatment
infant
young
children
uri
bronchiol
symptom
may
alter
viral
test
pathogen
identif
howev
patient
hospit
uri
privat
room
avail
cohort
recommend
addit
isol
precaut
employ
prevent
transmiss
specif
pathogen
known
method
transmiss
ie
aerosol
contact
minim
risk
hai
rsv
transmiss
may
optim
prevent
use
contact
isol
precaut
gown
glove
wherea
spread
rhinoviru
influenza
prevent
droplet
precaut
mask
data
provid
multipl
investig
includ
studi
add
grow
bodi
evid
suggest
viral
coinfect
common
infant
young
children
uri
symptom
clinic
signific
multipl
pathogen
identifi
quantit
viral
load
qualit
method
present
studi
question
various
report
differ
degre
clinic
import
detect
dead
noninfecti
viru
particl
molecular
assay
theoret
possibl
possibl
asymptomat
carriag
exampl
svpcr
array
rp
detect
mycoplasma
pneumonia
chlamydophila
pneumonia
report
persist
long
activ
infect
resolv
clinic
relev
transmiss
agent
requir
clinic
correl
contrast
b
pertussi
thought
caus
prolong
np
colon
may
becom
undetect
even
molecular
techniqu
shortli
characterist
whoop
develop
suggest
posit
result
b
pertussi
may
indic
detect
true
pathogen
note
patient
coinfect
heining
et
al
suggest
coinfect
virus
rsv
hmpv
bordetella
spp
rare
viral
coinfect
truli
increas
diseas
sever
may
multipl
infect
overrepres
studi
sampl
patient
seek
evalu
ed
especi
admit
hospit
addit
agent
known
yet
unknown
may
also
caus
uri
children
base
review
publish
pediatr
literatur
use
molecular
techniqu
identifi
respiratori
pathogen
report
rate
coinfect
pathogen
combin
would
requir
combin
isol
vari
estim
total
sampl
test
note
combin
isol
precaut
routin
recommend
respiratori
virus
includ
adenoviru
known
mechan
transmiss
estim
rate
pathogen
requir
combin
isol
precaut
would
even
higher
detect
adenoviru
alon
includ
studi
consid
mix
adenoviru
infect
children
test
pathogen
requir
droplet
contact
isol
precaut
svpcr
array
rp
detect
larg
number
pathogen
multipl
coinfect
children
uri
seek
medic
care
children
hospit
mani
requir
combin
contact
droplet
isol
precaut
therefor
center
continu
use
combin
isol
contact
droplet
precaut
hospit
children
uri
symptom
yearround
maintain
inpati
uri
symptom
durat
ill
hospit
discharg
patient
place
combin
isol
cohort
upon
admiss
privat
room
avail
although
cohort
patient
base
symptom
rang
pathogen
cultur
rapid
diagnost
test
exist
full
impact
rapid
respiratori
test
platform
svpcr
array
rp
may
allow
focus
isol
cohort
patient
futur
need
studi
like
mani
issu
hospit
infect
control
causat
difficult
prove
increas
decreas
hai
rate
multifactori
hospit
epidemiologist
chm
track
report
hai
rate
rsv
detect
rat
cultur
januari
april
annual
benchmark
hai
respiratori
virus
routin
monitor
year
prior
initi
combin
droplet
contact
isol
averag
rsv
hai
rate
per
patient
day
rsv
case
unpublish
data
implement
combin
isol
rate
rsv
case
unpublish
data
differ
signific
p
howev
target
infect
control
intervent
includ
specif
viral
test
isol
precaut
cohort
report
associ
prevent
hai
cost
save
center
low
number
influenza
strain
detect
may
reflect
time
influenza
season
winter
influenza
peak
octob
decemb
winter
almost
influenza
occur
januari
march
thu
littl
influenza
detect
methodolog
studi
period
strength
studi
larg
sampl
size
broad
age
rang
enrol
pediatr
patient
sampl
studi
use
sensit
molecular
methodbas
detect
svpcr
array
rp
limit
includ
data
obtain
singl
center
sampl
obtain
analyz
may
august
data
patient
clinic
cours
record
enrol
note
respiratori
molecular
diagnost
sampl
test
includ
studi
other
possibl
pcr
test
respiratori
sampl
yield
posit
result
may
due
dead
virion
detect
oppos
activ
viral
replic
pediatr
patient
uri
symptom
infect
common
pathogen
includ
rhinovirus
detect
sensit
molecular
assay
util
howev
patient
often
neg
rat
viral
cultur
result
limit
sensit
inher
detect
capabl
assay
nearli
patient
uri
symptom
age
month
posit
svpcr
array
rp
result
least
pathogen
coinfect
present
test
test
posit
least
pathogen
pathogen
pathogen
combin
detect
particip
test
studi
find
suggest
combin
contact
droplet
isol
precaut
gown
glove
mask
may
warrant
prevent
hai
pediatr
inpati
uri
studi
need
confirm
find
assess
effect
combin
isol
precaut
prevent
hai
pediatr
hospit
